BI-44847 is a selective and orally active inhibitor of the sodium-glucose cotransporter 2 (SGLT2), primarily targeting glucose reabsorption in the kidneys. This compound is known to enhance urinary glucose excretion (UGE) and reduce HbA1c levels, thus improving both fasting and postprandial glucose levels. BI-44847 is valuable for research applications focused on understanding and treating type 2 diabetes mellitus (T2DM).
BI-44847 is a selective and orally active inhibitor of the sodium-glucose cotransporter 2 (SGLT2), primarily targeting glucose reabsorption in the kidneys. This compound is known to enhance urinary glucose excretion (UGE) and reduce HbA1c levels, thus improving both fasting and postprandial glucose levels. BI-44847 is valuable for research applications focused on understanding and treating type 2 diabetes mellitus (T2DM).
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
